DESTINY Breast06 Subgroup Analysis
DESTINY-Breast06: T-DXd vs Chemotherapy by Pace of Progression on Previous ET in Patients With HR+/HER2-Low or HER2-Ultralow MBC

Released: December 18, 2024

Expiration: June 17, 2025

Activity

Progress
1
Course Completed